Product Information
HALOBETASOL PROP 0.05% CREAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.6480 per GM under NDC 45802012935. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 16, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802012935
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
HALOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA077123FDA Approved
12/16/2004
TE Code
AB
On Market Since
8/4/2008
Pharmacological Classes
Price Statistics
The NADAC for HALOBETASOL PROP 0.05% CREAM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 82.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6480 per GM |
|---|---|
| All-time high | $4.1004 (Jan 14, 2015) |
| All-time low | $0.5784 (May 17, 2023) |
| 52-week high | $0.7301 |
| 52-week low | $0.6480 |
| Median price | $1.2092 |
| Average price | $1.8814 |
| Largest weekly change | +44.2% (Jun 21, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Halobetasol Propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Halobetasol Propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOBETASOL PROP 0.05% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for HALOBETASOL PROP 0.05% CREAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.6480 per GM (NDC 45802012935), effective Sep 30, 2026.
How has the price of HALOBETASOL PROP 0.05% CREAM changed over time?
Over the history we have for it, the NADAC for HALOBETASOL PROP 0.05% CREAM has declined 82.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HALOBETASOL PROP 0.05% CREAM?
Since Nov 28, 2013, the NADAC for HALOBETASOL PROP 0.05% CREAM has ranged from a low of $0.5784 (May 17, 2023) to a high of $4.1004 (Jan 14, 2015), with a median of $1.2092 per GM.
Are there cheaper alternatives to HALOBETASOL PROP 0.05% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of HALOBETASOL PROP 0.05% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HALOBETASOL PROP 0.05% CREAM?
HALOBETASOL PROP 0.05% CREAM (NDC 45802012935) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.